Amgen Stock: Is AMGN Outperforming the Healthcare Sector? Amgen has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects. Barchart · Mar 4, 2025
Wall Street Predicts This Dividend Stock to Soar 31%: Should You Buy The Dip Now? Amgen stock is an attractive buy on the dip for passive income-focused investors. Barchart · Feb 12, 2025
Earnings Miss? Amgen’s Dividend Still a Bright Spot AMGN stock is down over 1% despite beating revenue and earnings estimates; investors are selling the news on the company’s latest obesity drug and weak guidance MarketBeat · Feb 5, 2025
Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs. Barchart · Feb 4, 2025
Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names. Barchart · Feb 4, 2025
Are Wall Street Analysts Predicting Amgen Stock Will Climb or Sink? Despite Amgen's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. Barchart · Feb 3, 2025
Amgen’s Q4 2024 Earnings: What to Expect Drug manufacturing giant Amgen is expected to announce its fourth-quarter results in the upcoming month and analysts expect single-digit growth in earnings. Barchart · Jan 10, 2025
Build a Bulletproof Portfolio with These Three Diversified Dividend Stocks Learn how diversification, careful screening, and key metrics like payout ratios and yields can help build a strong, income-generating portfolio for the long term. Barchart · Jan 7, 2025
Selling Covered Calls On The Dogs Of The Dow Stocks The Dogs of the Dow is a long standing wall street strategy for investing in the stock market that involves purchasing the 10 highest yielding Dow Jones stocks. Barchart · Dec 27, 2024
Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair? Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies. MarketBeat · Dec 6, 2024
Is Amgen Stock Underperforming the Dow? Despite pharma giant Amgen trailing behind the Dow index over the past three months, analysts remain cautiously bullish about the stock's growth potential. Barchart · Dec 4, 2024
3 Biotech Stocks with Promising Pipelines to Watch As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene editing and precision medicine transforming healthcare, fundamentally solid biotech stocks such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) are gaining traction. With promising innovations, these stocks could be prime investment opportunities.… StockNews.com · Nov 29, 2024
Stock Market Today: The S&P 500 Reclaims the 6K Level Investors see Scott Bessent as a safe shepherd of the economy as the president-elect burnishes his "Tariff Man" reputation. Kiplinger · Nov 26, 2024
Stocks Gain on Positive Corporate News and a Jump in US Consumer Confidence The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.45%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM... Barchart · Nov 26, 2024
Barchart · Nov 26, 2024 Stocks Climb on Positive Corporate News The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.48%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM...
Benzinga · Nov 26, 2024 Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau Amgen's Phase 2 MariTide trial showed ~20% weight loss at 52 weeks, cardiometabolic improvements, and no significant safety issues.
Barchart · Oct 23, 2024 3 Top Healthcare Stocks to Buy for Growth and Dividends Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and strategic moves.
Barchart · Sep 4, 2024 Is Amgen Stock Outperforming the Nasdaq? Amgen has surpassed the Nasdaq recently, and analysts are cautiously optimistic about its future potential.
Barchart · Aug 21, 2024 AMGN Bullish Diagonal Trade Targets a Price of $350 by October 18th A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio.
Barchart · Aug 9, 2024 Are Wall Street Analysts Bullish on Amgen Stock? Amgen has outperformed the broader market over the past year, yet Wall Street analysts remain cautiously optimistic about the stock’s prospects.
Barchart · Jul 17, 2024 What You Need to Know Ahead of Amgen's Earnings Release Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.
Kiplinger · Jun 24, 2024 The Future of Weight-Loss Drugs for Investors Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.
International Business Times UK · May 23, 2024 Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.
StockNews.com · May 17, 2024 3 Biotech Stocks Poised for May Surges The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.
Barchart · May 3, 2024 Stocks Close Higher as the Outlook Improves for Fed Rate Cuts The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.99%. US stock indexes Friday settled moderately higher, with the S&P 500 and Nasdaq 100...